Skip to main content
JADPRO Live 2024 Main banner
Icon Legend
ICONS KEY
CE Credit Available
CE Credit Available
Pharmacology Credit Available
Pharmacology Credit Available
Poster Activities
Poster Activities
Surgical Oncology
Surgical Oncology
Back

JADPRO Live 2024

Livestream

Main Stage

Advancing Care for Patients With Resectable NSCLC

Saturday, November 16, 2024
11:30 AM – 12:30 PM CT
Location: Grapevine Ballroom
CE: 1.00 credits/hours
CE Credit Available Pharmacology Credit Available

Disclosures:

Danielle M. Fournier has no relevant financial relationships to disclose.
Sarah Anderson has no relevant financial relationships to disclose.

Learning Objectives:

  • Recall relevant clinical trials leading to recent FDA approvals of new systemic treatment options for patients with resectable non-small cell lung cancer (NSCLC), and related updates to clinical practice guidelines
  • Identify recommended biomarker tests needed to plan treatment for patients with resectable NSCLC
  • Incorporate evidence-based best practices for monitoring and managing adverse events associated with neoadjuvant and adjuvant systemic therapy for patients with resectable NSCLC